203 results
CORRESP
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
5 Aug 09
Correspondence with SEC
12:00am
was a qualitative goal and not objectively determinable, the compensation committee attributed 10% achievement to such goal based on its subjective assessment … was a qualitative goals and not objectively determinable, the compensation committee attributed 10% achievement to such goal based on its subjective assessment
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
13 Dec 05
Results of Operations and Financial Condition
12:00am
to the company’s updated assessment in December 2005 of the timing of certain clinical trials.
Overall, given the fixed level of amortization … to the company’s updated assessment in December 2005 of the timing of certain clinical trials. Additionally, the company had previously sold rights to Royalty
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 Dec 98
Registration of securities for employees
12:00am
2000
related issues. This program includes the review and assessment of information
technology and non-information technology systems, as well as third … parties with
which we have a material relationship. This program consists of four phases:
inventory, risk assessment, problem validation, and problem
8-K
EX-99.1
w6an2d4n 9l8f
9 Feb 15
Ligand Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
POS AM
5x5nfb 2nv
12 Apr 06
Prospectus update (post-effective amendment)
12:00am
CORRESP
dj8utnb3m
3 Feb 06
Correspondence with SEC
12:00am
CORRESP
1b83pg yyfam4x
2 Dec 14
Correspondence with SEC
12:00am
S-4
EX-10.3
mejvw6vkixpvvan
9 Jul 98
Registration of securities issued in business combination transactions
12:00am